World
Standalone Financial Results for the Quarter ended 30th June, 2020
Highlights Unprecedented disruption in operations due to nationwide lockdowns weighed on performance. Strong performance by FMCG-Others Segment: Revenue up 12.2%...
Enrich collaborates with Trip.com to make travel a more rewarding experience
KLIA, 24 July 2020: Malaysia Airlines’ frequent flyer programme Enrich has partnered with the leading international travel services provider Trip.com...
Emirates covers customers from COVID-19 expenses, in industry-leading initiative to boost travel confidence
World’s first airline to offer its passengers free cover for COVID-19 medical expenses and quarantine costs, in a unique assurance...
ABB appoints Theodor Swedjemark as Chief Communications Officer
Zurich, Switzerland | 2020-07-22 As of August 1, 2020, Theodor Swedjemark (40) will join the Executive Committee of ABB as...
Q2 2020 results
Zurich, Switzerland | 2020-07-22 Orders $6.1 billion, -18%; comparable -14%1 Revenues $6.2 billion, -14%; comparable -10% Income from operations $571...
Wipro to launch 5G edge services solutions suite
The solutions extend Wipro’s BoundaryLess Enterprise – Universal Edge portfolio to offer real-time visibility and data insights for holistic...
Amazon Pay launches Car and Bike Insurance with easy online purchase
Partners with Acko to offer insurance at low prices. Exclusive benefits for Prime members Bangalore, 23 July 2020: Amazon Pay...
Global Call to Boost Diversity of Genomic Medicine
The COVID-19 pandemic exposed existing global inequities in health systems and gaps in the understanding of how disease may affect...
Amazon 2020 SMB Impact Report Highlights Success for Small and Medium-Sized Businesses Despite COVID-19; American Sellers Average $160,000 in Annual Sales
More than 2 million independent businesses work with Amazon in the U.S. American small and medium-sized businesses sold 3.4 billion...
COVID-19 vaccine AZD1222 showed robust immune responses in all participants in Phase I/II trial
20 July 2020 14:40 BST Interim data showed strong antibody and T-cell responses Interim results from the ongoing Phase I/II...
